Literature DB >> 31020697

Spotlight Commentary: What's new with the old drug aspirin in older adults?

Andrew James Webb1, Pietro Minuz2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31020697      PMCID: PMC6595375          DOI: 10.1111/bcp.13929

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  Spotlight Commentary: What's new with the old drug aspirin in older adults?

Authors:  Andrew James Webb; Pietro Minuz
Journal:  Br J Clin Pharmacol       Date:  2019-04-25       Impact factor: 4.335

2.  Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study.

Authors:  Emilie M Gieling; Hendrika A van den Ham; Hein van Onzenoort; Jacqueline Bos; Cornelis Kramers; Anthonius de Boer; Frank de Vries; Andrea M Burden
Journal:  Br J Clin Pharmacol       Date:  2017-03-24       Impact factor: 4.335

3.  Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people.

Authors:  Ilaria Ardoino; Raffaella Rossio; Donnatella Di Blanca; Alessandro Nobili; Luca Pasina; Pier Mannuccio Mannucci; Flora Peyvandi; Carlotta Franchi
Journal:  Br J Clin Pharmacol       Date:  2017-08-01       Impact factor: 4.335

4.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

5.  Effect of Aspirin on All-Cause Mortality in the Healthy Elderly.

Authors:  John J McNeil; Mark R Nelson; Robyn L Woods; Jessica E Lockery; Rory Wolfe; Christopher M Reid; Brenda Kirpach; Raj C Shah; Diane G Ives; Elsdon Storey; Joanne Ryan; Andrew M Tonkin; Anne B Newman; Jeff D Williamson; Karen L Margolis; Michael E Ernst; Walter P Abhayaratna; Nigel Stocks; Sharyn M Fitzgerald; Suzanne G Orchard; Ruth E Trevaks; Lawrence J Beilin; Geoffrey A Donnan; Peter Gibbs; Colin I Johnston; Barbara Radziszewska; Richard Grimm; Anne M Murray
Journal:  N Engl J Med       Date:  2018-09-16       Impact factor: 91.245

6.  Incidence and cost of medication harm in older adults following hospital discharge: a multicentre prospective study in the UK.

Authors:  Nikesh Parekh; Khalid Ali; Jennifer M Stevenson; J Graham Davies; Rebekah Schiff; Tischa Van der Cammen; Jatinder Harchowal; James Raftery; Chakravarthi Rajkumar
Journal:  Br J Clin Pharmacol       Date:  2018-05-31       Impact factor: 4.335

  6 in total
  1 in total

1.  Spotlight Commentary: What's new with the old drug aspirin in older adults?

Authors:  Andrew James Webb; Pietro Minuz
Journal:  Br J Clin Pharmacol       Date:  2019-04-25       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.